TrueBlue Stock Forecast, Price & News

TrueBlue (NYSE:TBI) Frequently Asked Questions

Is TrueBlue a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TrueBlue stock.
View analyst ratings for TrueBlue or view top-rated stocks.

How has TrueBlue's stock price been impacted by Coronavirus (COVID-19)?

TrueBlue's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TBI stock has increased by 101.0% and is now trading at $26.83.
View which stocks have been most impacted by COVID-19.

When is TrueBlue's next earnings date?

TrueBlue is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for TrueBlue.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) announced its earnings results on Sunday, October, 24th. The business services provider reported $0.59 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.60 by $0.01. The business services provider had revenue of $577.03 million for the quarter, compared to analyst estimates of $570.85 million. TrueBlue had a trailing twelve-month return on equity of 12.55% and a net margin of 2.39%. The business's revenue was up 21.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.24 EPS.
View TrueBlue's earnings history.

What price target have analysts set for TBI?

3 analysts have issued 12-month price objectives for TrueBlue's shares. Their forecasts range from $23.00 to $35.00. On average, they anticipate TrueBlue's share price to reach $29.00 in the next year. This suggests a possible upside of 8.1% from the stock's current price.
View analysts' price targets for TrueBlue or view top-rated stocks among Wall Street analysts.

Who are TrueBlue's key executives?

TrueBlue's management team includes the following people:

• A. Patrick Beharelle, President, Chief Executive Officer & Director
• Derrek L. Gafford, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Jeffrey S. Dirks, Chief Information & Technology Officer
• Garrett R. Ferencz, Chief Legal Officer & Executive Vice President
• Richard Christensen, Chief Accounting Officer & Senior Vice President

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue CEO Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among TrueBlue's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of TrueBlue's key competitors?

Some companies that are related to TrueBlue include Tradeweb Markets (TW), Robert Half International (RHI), ASGN (ASGN), ManpowerGroup (MAN), Insperity (NSP), Korn Ferry (KFY), Kforce (KFRC), Heidrick & Struggles International (HSII), Kelly Services (KELYA), Barrett Business Services (BBSI) and Hudson Global (HSON).
View all of TBI's competitors.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

What is TrueBlue's stock symbol?

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by a number of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.07%), Diversified Trust Co (0.04%), Crossmark Global Holdings Inc. (0.03%) and Parallel Advisors LLC (0.01%). Company insiders that own TrueBlue stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Richard Christensen, Steven C Cooper and Taryn R Owen.
View institutional ownership trends for TrueBlue.

Which major investors are selling TrueBlue stock?

TBI stock was sold by a variety of institutional investors in the last quarter, including Diversified Trust Co, Parallel Advisors LLC, and State of Alaska Department of Revenue. Company insiders that have sold TrueBlue company stock in the last year include A Patrick Beharelle, Carl Schweihs, Derrek Lane Gafford, Richard Christensen, Steven C Cooper, and Taryn R Owen.
View insider buying and selling activity for TrueBlue or view top insider-selling stocks.

Which major investors are buying TrueBlue stock?

TBI stock was bought by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc..
View insider buying and selling activity for TrueBlue or or view top insider-buying stocks.

How do I buy shares of TrueBlue?

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TrueBlue's stock price today?

One share of TBI stock can currently be purchased for approximately $26.83.

How much money does TrueBlue make?

TrueBlue has a market capitalization of $951.96 million and generates $1.85 billion in revenue each year. The business services provider earns $-141.84 million in net income (profit) each year or $1.41 on an earnings per share basis.

How many employees does TrueBlue have?

TrueBlue employs 5,200 workers across the globe.

What is TrueBlue's official website?

The official website for TrueBlue is www.trueblue.com.

Where are TrueBlue's headquarters?

TrueBlue is headquartered at 1015 A STREET, TACOMA WA, 98402.

How can I contact TrueBlue?

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at (253) 383-9101, via email at [email protected], or via fax at 877-733-0399.